ANGO
Price
$10.11
Change
+$0.10 (+1.00%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
411.62M
35 days until earnings call
RGEN
Price
$122.26
Change
+$3.38 (+2.84%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
6.87B
68 days until earnings call
Interact to see
Advertisement

ANGO vs RGEN

Header iconANGO vs RGEN Comparison
Open Charts ANGO vs RGENBanner chart's image
AngioDynamics
Price$10.11
Change+$0.10 (+1.00%)
Volume$6.81K
Capitalization411.62M
Repligen
Price$122.26
Change+$3.38 (+2.84%)
Volume$21.81K
Capitalization6.87B
ANGO vs RGEN Comparison Chart in %
Loading...
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANGO vs. RGEN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a StrongBuy and RGEN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ANGO: $10.01 vs. RGEN: $118.88)
Brand notoriety: ANGO and RGEN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANGO: 49% vs. RGEN: 64%
Market capitalization -- ANGO: $411.62M vs. RGEN: $6.87B
ANGO [@Pharmaceuticals: Other] is valued at $411.62M. RGEN’s [@Pharmaceuticals: Other] market capitalization is $6.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANGO’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • ANGO’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEN is a better buy in the long-term than ANGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANGO’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 4 bullish TA indicator(s).

  • ANGO’s TA Score: 4 bullish, 6 bearish.
  • RGEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RGEN is a better buy in the short-term than ANGO.

Price Growth

ANGO (@Pharmaceuticals: Other) experienced а +9.64% price change this week, while RGEN (@Pharmaceuticals: Other) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.19%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +21.40%.

Reported Earning Dates

ANGO is expected to report earnings on Oct 02, 2025.

RGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+4.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEN($6.87B) has a higher market cap than ANGO($412M). ANGO YTD gains are higher at: 9.279 vs. RGEN (-17.410). RGEN has higher annual earnings (EBITDA): 99.5M vs. ANGO (1.74M). RGEN has more cash in the bank: 709M vs. ANGO (55.9M). ANGO has less debt than RGEN: ANGO (5M) vs RGEN (686M). RGEN has higher revenues than ANGO: RGEN (674M) vs ANGO (292M).
ANGORGENANGO / RGEN
Capitalization412M6.87B6%
EBITDA1.74M99.5M2%
Gain YTD9.279-17.410-53%
P/E RatioN/A511.11-
Revenue292M674M43%
Total Cash55.9M709M8%
Total Debt5M686M1%
FUNDAMENTALS RATINGS
ANGO vs RGEN: Fundamental Ratings
ANGO
RGEN
OUTLOOK RATING
1..100
1758
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
9591
PRICE GROWTH RATING
1..100
5177
P/E GROWTH RATING
1..100
562
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANGO's Valuation (69) in the Medical Specialties industry is in the same range as RGEN (95) in the Biotechnology industry. This means that ANGO’s stock grew similarly to RGEN’s over the last 12 months.

ANGO's Profit vs Risk Rating (92) in the Medical Specialties industry is in the same range as RGEN (100) in the Biotechnology industry. This means that ANGO’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's SMR Rating (91) in the Biotechnology industry is in the same range as ANGO (95) in the Medical Specialties industry. This means that RGEN’s stock grew similarly to ANGO’s over the last 12 months.

ANGO's Price Growth Rating (51) in the Medical Specialties industry is in the same range as RGEN (77) in the Biotechnology industry. This means that ANGO’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for ANGO (56) in the Medical Specialties industry. This means that RGEN’s stock grew somewhat faster than ANGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANGORGEN
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 16 days ago
75%
Declines
ODDS (%)
Bearish Trend 18 days ago
72%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAIDX9.82N/A
N/A
Lord Abbett International Value I
SVFDX79.96N/A
N/A
Smead Value R1
ACWEX16.45N/A
N/A
Cavanal Hill World Energy C
FIQFX48.78N/A
N/A
Fidelity Advisor China Region Z
ASAPF0.21N/A
-1.28%
Aurora Spine Corp

ANGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with MXCT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then MXCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
+2.25%
MXCT - ANGO
36%
Loosely correlated
+0.72%
ICUI - ANGO
32%
Poorly correlated
+0.54%
RGEN - ANGO
32%
Poorly correlated
-1.34%
BLFS - ANGO
32%
Poorly correlated
-0.86%
A - ANGO
31%
Poorly correlated
+0.33%
More